NASDAQ:PETS PetMed Express (PETS) Stock Price, News & Analysis $1.18 -0.01 (-0.84%) Closing price 04:00 PM EasternExtended Trading$1.18 0.00 (0.00%) As of 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC Filings About PetMed Express Stock (NASDAQ:PETS) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get PetMed Express alerts:Sign Up Key Stats Today's Range$1.17▼$1.2050-Day Range$1.15▼$1.8952-Week Range$1.15▼$4.10Volume12,512 shsAverage Volume114,916 shsMarket Capitalization$25.58 millionP/E RatioN/ADividend YieldN/APrice Target$1.40Consensus RatingStrong Sell Company Overview PetMed Express, Inc., doing business as PetMeds, is an online retailer of prescription and nonprescription medications and health products for dogs, cats and other household pets. The company offers products used to treat or prevent conditions such as allergies, infections, parasites and chronic illnesses, including prescription medicines, flea and tick treatments, heartworm preventatives, supplements and other animal-health products. In addition to medications, PetMeds sells pet food, treats, vitamins, wellness products and selected supplies. Customers can place orders through the company’s website and other direct-to-consumer channels, with prescription orders generally requiring authorization from a licensed veterinarian. PetMeds primarily serves pet owners in the United States. Founded in 1996 and previously known as 1-800-PetMeds, the company has built its business around convenient home delivery and consumer access to pet-health products. PetMed Express is headquartered in Delray Beach, Florida, and its common stock trades on the Nasdaq Capital Market under the symbol PETS.AI Generated. May Contain Errors. Read More PetMed Express Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks41st Percentile Overall ScorePETS MarketRank™: 2.038187702265 of 5 starsPetMed Express scored higher than 41% of companies evaluated by MarketBeat, and ranked 354th out of 484 stocks in the consumer discretionary sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.6 / 5Analyst RatingStrong Sell Consensus RatingPetMed Express has received a consensus rating of Strong Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 3 sell ratings.Upside PotentialPetMed Express has a consensus price target of $1.40, representing about 18.6% upside from its current price of $1.18.Amount of Analyst CoveragePetMed Express has only been the subject of 3 research reports in the past 90 days.Read more about PetMed Express' stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for PetMed Express are expected to grow in the coming year, from ($0.50) to ($0.35) per share.Price to Book Value per Share RatioPetMed Express has a P/B Ratio of 0.87. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about PetMed Express' valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted4.19% of the float of PetMed Express has been sold short.Short Interest Ratio / Days to CoverPetMed Express has a short interest ratio ("days to cover") of 7.4.Change versus previous monthShort interest in PetMed Express has recently increased by 29.61%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldPetMed Express does not currently pay a dividend.Dividend GrowthPetMed Express does not have a long track record of dividend growth. News and Social Media3.1 / 5News Sentiment0.91 News SentimentPetMed Express has a news sentiment score of 0.91. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.54 average news sentiment score of Consumer Discretionary companies.News Coverage This WeekMarketBeat has tracked 2 news articles for PetMed Express this week, compared to 2 articles on an average week.Search Interest6 people have searched for PETS on MarketBeat in the last 30 days. Company Ownership0.8 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, PetMed Express insiders have not sold or bought any company stock.Percentage Held by Insiders1.30% of the stock of PetMed Express is held by insiders.Percentage Held by Institutions73.33% of the stock of PetMed Express is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about PetMed Express' insider trading history. Receive PETS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for PetMed Express and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. PETS Stock News HeadlinesPetMed Express, Inc. to Report Second Quarter Fiscal Year 2027 Financial Results on Tuesday, November 10, 2026October 27 at 4:15 PM | globenewswire.comPetMed Express consensus price target cut by 34.88% to $1.43October 2, 2026 | msn.comBuffett's Final Warning: "The Dollar Is Going to Hell"In 2025, the dollar lost 12% in value. Real inflation hit 5%+. 12% + 5% = 17% purchasing power gone. And it's happening again this year. And next year. And the year after that. The people who understand this are already moving. In a free presentation I just recorded, I'm revealing what we call "The 2026 AI Gold Rush." The ONE AI-linked asset class the U.S. government has no choice but to fuel… and BlackRock, Goldman Sachs, and 170 public companies are already positioning into it. The same strategy that delivered 12,480% for Mastercard investors since its 2006 IPO. Sitting idle isn't "playing it safe." It's the most expensive decision you'll make this decade.October 29 at 1:00 AM | Decentralized Masters (Ad)PetMeds Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)October 2, 2026 | globenewswire.comPetMed Express Amends Plan for New CEO Equity AwardsSeptember 28, 2026 | tipranks.comAnalysts Conflicted on These Healthcare Names: Petmed Express (PETS) and Accendra Health (ACH)September 22, 2026 | theglobeandmail.comPetMeds Appoints Tamar Elkeles As Independent DirectorSeptember 22, 2026 | rttnews.comPetMed Express, Inc. Announces Appointment of Tamar Elkeles as Director, Effective September 17, 2026September 21, 2026 | marketscreener.comMSee More Headlines PETS Stock Analysis - Frequently Asked Questions How have PETS shares performed this year? PetMed Express' stock was trading at $3.20 at the start of the year. Since then, PETS shares have decreased by 63.1% and is now trading at $1.18. How were PetMed Express' earnings last quarter? PetMed Express, Inc. (NASDAQ:PETS) posted its earnings results on Thursday, August, 13th. The company reported ($0.28) EPS for the quarter, missing the consensus estimate of $0.12 by $0.40. The company had revenue of $41.02 million for the quarter, compared to analyst estimates of $71 million. PetMed Express had a negative trailing twelve-month return on equity of 91.69% and a negative net margin of 17.34%. Read the conference call transcript. How do I buy shares of PetMed Express? Shares of PETS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of PetMed Express own? Based on aggregate information from My MarketBeat watchlists, some other companies that PetMed Express investors own include Intel (INTC), NVIDIA (NVDA), Alibaba Group (BABA), AT&T (T), Ford Motor (F), Pfizer (PFE) and Johnson & Johnson (JNJ). Company Calendar Last Earnings8/13/2026Today10/29/2026Next Earnings (Estimated)11/10/2026Fiscal Year End3/31/2027Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (7m+) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 PETS's financial health is in the Red zone, according to TradeSmith. PETS has been in this zone for over 7 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorConsumer Discretionary Industry Specialty Retail Sub-IndustryOther Specialty Retail Current SymbolNASDAQ:PETS CIK1040130 Webwww.petmeds.com Phone(561) 426-4444Fax561-526-4445Employees189Year Founded1996Price Target and Rating Average Price Target for PetMed Express$1.40 High Price Target$1.40 Low Price Target$1.40 Potential Upside/Downside+18.6%Consensus RatingStrong Sell Rating Score (0-4)1.00 Research Coverage3 Analysts Profitability EPS (Trailing Twelve Months)($1.38) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$57.29 million Net Margins-17.34% Pretax Margin-17.38% Return on Equity-91.69% Return on Assets-35.15% Debt Debt-to-Equity RatioN/A Current Ratio0.68 Quick Ratio0.47 Sales & Book Value Annual Sales$179.02 million Price / Sales0.14 Cash Flow$0.31 per share Price / Cash Flow3.85 Book Value$1.35 per share Price / Book0.87Miscellaneous Outstanding Shares21,680,000Free Float21,397,000Market Cap$25.58 million OptionableOptionable Beta0.83 Social Links 7 Energy Stocks to Buy and Hold ForeverOil still powers the global economy, but AI is reshaping the energy opportunity. Discover seven stocks spanning traditional energy, infrastructure, and next-generation power.Get This Free Report This page (NASDAQ:PETS) was last updated on 10/29/2026 by MarketBeat.com Staff. From Our PartnersFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...Weiss Ratings | SponsoredThe "velvet rope" stock setups hiding from regular indicatorsK.I.R.A. is a new trading engine built to flag market setups before they show up on standard charts. Former...The TradingPub | SponsoredThe investigation Porter spent tens of thousands to documentPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...Porter & Company | SponsoredA free stock pick, from me to youElon's paid this chip supplier since 2012. When NVIDIA tried to buy the company, he fought the deal. Withou...Behind the Markets | Sponsored3 Stocks for AI’s Next WaveMarc Chaikin, a nearly 60-year market veteran, built the stock-rating system that flagged 43 of the market's t...Chaikin Analytics | SponsoredLast note from me on thisJoel Peterson's free workshop breaks down a three step, three color system that works across stocks, ETFs, gol...The Cycle Code | SponsoredElon Musk's Intel Deal Already Jumped 177 Percent This YearElon Musk's April 2026 partnership with Intel sent shares climbing 177% within two months. Jeff Brown, the ...Brownstone Research | SponsoredThe Claude AI company doubled in value... you missed itIn May, Anthropic raised money at a $965 billion valuation. Now, ahead of its IPO, investors are reportedly di...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PetMed Express, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share PetMed Express With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
